CNS drugs discovery services

Central nervous system drugs discovery services

Fluofarma offers drug discovery services for central nervous system pathologies. Fluofarma combines large-scale screening in primary neuron cultures and reliable neurobiology tools that can help you identify and characterize your neuroprotective drugs.

Fluofarma developed several innovative tools for CNS drugs discovery services:

• Cellular models: Human engineered cell lines and primary culture of neurons grown in 96-well plates
• Neurodegeneration models: Cellular models that mimic neurodegeneration pathologies such as Parkinson’s disease or Alzheimer’s disease
• Molecular reporter: Human cell lines expressing proprietary recombinant biosensors measuring key steps of neurodegeneration

Fluofarma offers comprehensive CNS drugs discovery services:

• Large-scale screening of CNS drugs, in cell line or in primary cultures of neurons
• Selection of the good lead using our predictive neurodegeneration models
• Determination of the mechanism of action

For more information on our CNS drugs discovery services

If you need to have further details on our cns drugs discovery services, do not hesitate to contact us.